Folgen
Peter Gehlbach
Peter Gehlbach
Johns Hopkins University School of Medicine
Bestätigte E-Mail-Adresse bei jhmi.edu - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results
JA Haller, F Bandello, R Belfort Jr, MS Blumenkranz, M Gillies, J Heier, ...
Ophthalmology 118 (12), 2453-2460, 2011
8902011
Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema
Diabetic Retinopathy Clinical Research Network
Ophthalmology 114 (3), 525-536, 2007
7122007
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch …
IU Scott, MS Ip, PC VanVeldhuisen, NL Oden, BA Blodi, M Fisher, ...
Archives of ophthalmology 127 (9), 1115, 2009
6982009
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth
EJ Duh, HS Yang, I Suzuma, M Miyagi, E Youngman, K Mori, M Katai, ...
Investigative ophthalmology & visual science 43 (3), 821-829, 2002
4822002
Pigment epithelium‐derived factor inhibits retinal and choroidal neovascularization
K Mori, E Duh, P Gehlbach, A Ando, K Takahashi, J Pearlman, K Mori, ...
Journal of cellular physiology 188 (2), 253-263, 2001
4712001
AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization
K Mori, P Gehlbach, S Yamamoto, E Duh, DJ Zack, Q Li, KI Berns, ...
Investigative ophthalmology & visual science 43 (6), 1994-2000, 2002
3462002
Regression of ocular neovascularization in response to increased expression of pigment epithelium–derived factor
K Mori, P Gehlbach, A Ando, D McVey, L Wei, PA Campochiaro
Investigative ophthalmology & visual science 43 (7), 2428-2434, 2002
3292002
New steady-hand eye robot with micro-force sensing for vitreoretinal surgery
A Üneri, MA Balicki, J Handa, P Gehlbach, RH Taylor, I Iordachita
2010 3rd IEEE RAS & EMBS International Conference on Biomedical Robotics and …, 2010
3262010
Clinical protocol. An open-label, phase I, single administration, dose-escalation study of ADGVPEDF. 11D (ADPEDF) in neovascular age-related macular degeneration (AMD).
H Rasmussen, KW Chu, P Campochiaro, PL Gehlbach, JA Haller, ...
Human gene therapy 12 (16), 2029-2032, 2001
2232001
Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin
K Mori, A Ando, P Gehlbach, D Nesbitt, K Takahashi, D Goldsteen, ...
The American journal of pathology 159 (1), 313-320, 2001
2202001
Comparison of the modified Early Treatment Diabetic Retinopathy Study and mild macular grid laser photocoagulation strategies for diabetic macular edema
Diabetic Retinopathy Clinical Research Network
Archives of Ophthalmology 125 (4), 469, 2007
2192007
A sub-millimetric, 0.25 mN resolution fully integrated fiber-optic force-sensing tool for retinal microsurgery
I Iordachita, Z Sun, M Balicki, JU Kang, SJ Phee, J Handa, P Gehlbach, ...
International journal of computer assisted radiology and surgery 4, 383-390, 2009
2142009
Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis
EJ Duh, HS Yang, JA Haller, E De Juan, MS Humayun, P Gehlbach, ...
American journal of ophthalmology 137 (4), 668-674, 2004
2092004
Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative retinopathy and retinal detachment
K Ohno-Matsui, A Hirose, S Yamamoto, J Saikia, N Okamoto, P Gehlbach, ...
The American journal of pathology 160 (2), 711-719, 2002
2092002
A submillimetric 3-DOF force sensing instrument with integrated fiber Bragg grating for retinal microsurgery
X He, J Handa, P Gehlbach, R Taylor, I Iordachita
IEEE Transactions on Biomedical Engineering 61 (2), 522-534, 2013
1982013
Visual tracking and annotaton of clinically important anatomical landmarks for surgical interventions
MA Balicki, RH Taylor, GD Hager, PL Gehlbach, JT Handa, R Kumar
US Patent 9,814,392, 2017
1862017
Roy and Fraunfelder's current ocular therapy
FH Roy, FW Fraunfelder, FT Fraunfelder
Elsevier Health Sciences, 2008
1732008
Interventions for central serous chorioretinopathy: a network meta‐analysis
M Salehi, AS Wenick, HA Law, JR Evans, P Gehlbach
Cochrane Database of Systematic Reviews, 2015
1452015
Advanced glycation endproduct-induced aging of the retinal pigment epithelium and choroid: a comprehensive transcriptional response
J Tian, K Ishibashi, K Ishibashi, K Reiser, R Grebe, S Biswal, P Gehlbach, ...
Proceedings of the National Academy of Sciences 102 (33), 11846-11851, 2005
1422005
Increased expression of brain-derived neurotrophic factor preserves retinal function and slows cell death from rhodopsin mutation or oxidative damage
G Okoye, J Zimmer, J Sung, P Gehlbach, T Deering, H Nambu, S Hackett, ...
Journal of Neuroscience 23 (10), 4164-4172, 2003
1422003
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20